| Original language | English |
|---|---|
| Article number | PCN186 |
| Pages (from-to) | A463 |
| Journal | Value in health |
| Volume | 18 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Nov 2017 |
| Event | ISPOR 18th Annual European Congress 2015 - MiCo - Milano Congressi, Milan, Italy Duration: 7 Nov 2015 → 11 Nov 2015 Conference number: 18 https://www.ispor.org/event/index/2015milan |
Keywords
- Abonnement
Cite this
}
Cost-effectiveness and feasibility of implementing mri-guided neoadjuvant chemotherapy to treat er-positive her2-negative breast cancers in the Netherlands. / Miquel-Cases, Anna; Steuten, L.; van Harten, Willem H.
In: Value in health, Vol. 18, No. 7, PCN186, 11.2017, p. A463.Research output: Contribution to journal › Meeting Abstract › Academic
TY - JOUR
T1 - Cost-effectiveness and feasibility of implementing mri-guided neoadjuvant chemotherapy to treat er-positive her2-negative breast cancers in the Netherlands
AU - Miquel-Cases, Anna
AU - Steuten, L.
AU - van Harten, Willem H.
PY - 2017/11
Y1 - 2017/11
KW - Abonnement
U2 - 10.1016/j.jval.2015.09.1203
DO - 10.1016/j.jval.2015.09.1203
M3 - Meeting Abstract
VL - 18
SP - A463
JO - Value in health
JF - Value in health
SN - 1098-3015
IS - 7
M1 - PCN186
ER -